Deprecated: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in /home/dgjigroup/www/www/inc/parsefile.php on line 7
Dragon Jade International
Location: Dragon Jade International Limited » Selected Vegetables

WHY INVEST IN DRAGON JADE (OTCBB: DGJI)?

  • It becomes abundantly clear that traditional Chinese medicines (TCM) is going to be the next modality and prescribed TCM formulas will be viewed as powerful therapeutic cures. Dragon Jade pioneering endeavors in promoting better access and broader use of TCM will definitely be paid off and return of investments should be remarkable.

  • Dragon Jade in-depth understanding of how to carry out biomedical experimentation, clinical traits, systematic reviews and sampled surveys will surely help its selected traditional Chinese medicines partner companies to meet the western scientific disciplines of medicines or healthcare products.

  • Dragon Jade has extensive know- how techniques to implement and comply with the prescribed codes of practices and relevant laws and ordinances. These merits will definitely attract generous funds and revenues in the near future for there are far too many TCM companies are eager to seek assistance to help them deal with the tough FDA regulatory regime.

  • read more....
    Selected Vegetables

    Selected Vegetables is the world’s first herbal mixture successfully agreed by the Food and Drug Administration (FDA) to enter the phase III clinical trial under its supervision. The Phase III clinical trial of the Selected Vegetables is funded and officially supervised by National Cancer for Complementary and Alternative Medicine (NCCAM) and National Cancer Institute (NCI). Since the clinical trial of the Selected Vegetables is the first-ever herbal mixture accredited with such status in the history, it also marks an important break-through for herbs as an approved drug and medicine in the World.

    Selected Vegetables contains 19 natural ingredients. According to the studies conducted by Dr. Alexander Sun, the inventor of Selected Vegetables, the median survival time of inoperable Stage IIIB and Stage IV non-small cell lung cancer patients receiving the Selected Vegetables treatment reached 33.5 months, which is much longer than the median survival time of historical data of other anti-cancer drugs, which is about 6 to 12 months only. In addition, objective tumor response to Selected Vegetables was also observed in many patients.